This inventor holds 1 USPTO granted patent. Top assignee: Recursion Pharmaceuticals, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations in Drug Discovery by Mika Lindvall
Introduction
Mika Lindvall is an accomplished inventor based in Salt Lake City, UT. He has made significant contributions to the field of drug discovery through his innovative techniques. His work focuses on enhancing the efficiency of identifying potential drug candidates, which is crucial in the pharmaceutical industry.
Latest Patents
Mika Lindvall holds a patent titled "Techniques for data-enabled drug discovery." This patent describes a molecule exploration application that determines potential drug candidates during the drug discovery process. The application generates derived molecule specifications based on a query molecule specification and edit heuristics. It then performs mapping operations on these specifications to create mapped molecule specifications. Finally, the application conducts search operations on a catalog of molecules to identify potential drug candidates. This innovative approach allows for the efficient determination of additional drug development candidates during the drug discovery process. Mika holds 1 patent.
Career Highlights
Mika Lindvall is currently employed at Recursion Pharmaceuticals, Inc., where he continues to develop and refine his innovative techniques in drug discovery. His work at Recursion Pharmaceuticals has positioned him as a key player in the intersection of technology and pharmaceuticals.
Collaborations
Mika collaborates with talented professionals in his field, including Jorge Aguilera-Iparraguirre. Their combined expertise contributes to the advancement of drug discovery methodologies.
Conclusion
Mika Lindvall's contributions to drug discovery through his innovative patent demonstrate his commitment to improving the pharmaceutical industry. His work at Recursion Pharmaceuticals continues to pave the way for more efficient drug development processes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile